Spire Wealth Management Buys 2,187 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Spire Wealth Management boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 10.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,909 shares of the medical equipment provider's stock after buying an additional 2,187 shares during the period. Spire Wealth Management's holdings in Intuitive Surgical were worth $11,841,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Brighton Jones LLC boosted its stake in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after acquiring an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG grew its stake in Intuitive Surgical by 0.5% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after acquiring an additional 883 shares during the period. Wealthspire Advisors LLC increased its holdings in shares of Intuitive Surgical by 28.6% during the fourth quarter. Wealthspire Advisors LLC now owns 1,645 shares of the medical equipment provider's stock valued at $859,000 after acquiring an additional 366 shares in the last quarter. MONECO Advisors LLC raised its position in shares of Intuitive Surgical by 8.1% during the fourth quarter. MONECO Advisors LLC now owns 1,129 shares of the medical equipment provider's stock worth $589,000 after purchasing an additional 85 shares during the period. Finally, World Equity Group Inc. lifted its holdings in shares of Intuitive Surgical by 22.8% in the 4th quarter. World Equity Group Inc. now owns 512 shares of the medical equipment provider's stock worth $267,000 after purchasing an additional 95 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director now owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president now owns 907 shares in the company, valued at $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 over the last 90 days. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Up 2.4%

NASDAQ:ISRG traded up $12.56 during trading hours on Thursday, hitting $534.19. 1,965,145 shares of the company's stock traded hands, compared to its average volume of 1,672,340. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00. The business's fifty day simple moving average is $530.03 and its two-hundred day simple moving average is $536.86. The firm has a market cap of $191.46 billion, a P/E ratio of 78.33, a P/E/G ratio of 5.53 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the prior year, the business earned $1.50 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on ISRG shares. Barclays lowered their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Robert W. Baird cut their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Evercore ISI decreased their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. Finally, Royal Bank Of Canada decreased their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $588.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.